Aravis leads Series B financing in Evolva SA Totalling CHF 44 M followed by a reverse merger of Evolva with Arpida
Aravis first invested in Evolva SA when the fund led a CHF 21.8 M (USD 21.1 M) Series A round in August 2004/5. At that time Aravis was also instrumental in moving Evolva to Allschwil (Basel) in Switzerland. Aravis then went on to lead a second closing of this Series A to the value of CHF 12 M (USD 10.3 M) in December 2006.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.